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Abstract
In patients with Brugada syndrome, implantable cardioverter‐defibrillator (ICD) is the 
only demonstrated treatment that prevents sudden cardiac death. The progress in ICD 
technology improved the diagnosis and efficacy of implantable devices in the manage-
ment and treatment of ventricular tachycardia (VT) and ventricular fibrillation (VF). 
Recording of electrical events just before and after a delivered or aborted ICD therapy 
permits a more accurate characterization of the rhythm but also provides information 
on the electrical events preceding the arrhythmia. This chapter aims to gain insight into 
the mechanism of initiation and termination of spontaneous VF by analyzing intracar-
diac electrograms (IEGM) in Brugada patients implanted with ICDs. It has two parts: 
(1) update on ICD electrograms in Brugada syndrome patients, where we review the 
medical literature on ICD electrograms and their use for detecting electrical manifesta-
tions of Brugada syndrome, and (2) examples of ICD electrograms, from our own data-
base of patients affected by Brugada syndrome.
Keywords: Brugada syndrome, ICD, defibrillation, ventricular fibrillation, premature 
ventricular contractions, electrophysiological study
1. Introduction
Brugada syndrome is a clinical syndrome associated with ventricular tachycardia (VT) and 
ventricular fibrillation (VF), in patients who have no structural heart disease. ECG is the most 
useful tool for the diagnosis and shows right bundle branch block with ST elevation in right 
precordial leads. Due to the high recurrence rate of ventricular fibrillation, an implantable 
cardioverter‐defibrillator (ICD) is the accepted mode of treatment and it improves the long‐
term prognosis.
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Clinical studies suggest that spontaneous episodes of VF are induced by PVCs originating at 
the level of right ventricular outflow tract (RVOT). Abnormal electrophysiological features 
are present in this zone, with fragmented, low amplitude, late potentials. Programed ven-
tricular stimulation at the level of RVOT increases the chance of VF induction compared to 
RV apex.
The progress in ICD technology improved the diagnosis and treatment efficacy of implant-
able devices in the management of VT and VF in Brugada syndrome. Recording of electrical 
events before and after a delivered or aborted ICD therapy permits not only a more accurate 
characterization of the rhythm but also provides information on the electrical events preced-
ing the arrhythmia.
2. Mode of onset of ventricular fibrillation in Brugada syndrome
In Brugada syndrome, VF episodes can be preceded by PVCs or start suddenly without a 
preceding premature ventricular contractions (PVC). This classification assumes distinct 
electrophysiological mechanism for the two types of VF. Although very few PVCs are 
observed on Holter monitoring, in Brugada syndrome PVCs tend to occur more frequently 
before the initiation of VF, as well as ST segment elevation in precordial leads [1]. The 
mechanism that explains the association of the two phenomena is the marked shortening of 
the action potential in the RVOT which gives the ST elevation, and phase 2 reentry respon-
sible for PVC firing from the same area with short action potential, which initiates VF [2, 3]. 
Kofune et al. were able to identify the substrate of the Brugada syndrome by high‐resolu-
tion electroanatomical mapping. In patients with Brugada syndrome, they found that only 
the right ventricle is affected, the left being spared, and only a small area within the RVOT is 
responsible for the syndrome. At this level, they found low‐voltage potential with fraction-
ated electrograms. The conduction abnormality from the RVOT gives the final phenotypic 
expression of right precordial ST segment elevation [4]. Previous studies of Antzelevitch et 
al. demonstrated that at cellular level the action potential dome propagates from the normal 
epicardial sites to the epicardial site without dome leading to phase 2 reentry. As the reen-
try fails to propagate to the endocardium, it leads to closely coupled ventricular premature 
beats [5]. Specific triggers can lead to heterogeneous repolarization: fever or after exercise 
when the body temperature rises, and specific medication like: ajmaline, flecainide, and 
propafenone.
In the study of Kakishita et al., frequent PVCs before the onset of VF were recorded in 67% 
of the patients. The morphology of preceding PVC electrogram (far‐field and near‐field) was 
identical to the PVC that initiated VF. Additionally, different VF episodes seen in the same 
patient were initiated by the same PVC morphology. The rest of 33% of patients had episodes 
of VF without preceding PVCs.
A long‐short sequence is very unlikely to initiate VF in Brugada syndrome and pause‐depen-
dent VF is very rare [6].
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3. Coupling interval of the VF initiating PVC
It is well known that PVCs occurring near the peak of the T‐wave (ventricular vulnerable 
period) may lead to ventricular fibrillation. However, in Brugada syndrome, the onset of 
PVCs inducing VF are close to the end of the T‐wave. Kakishita et al. found a coupling 
interval of 388 ms for the PVC initiating VF in patients with Brugada syndrome. Kasanuki 
et al found a value of > 300 ms coupling interval for the PVC inducing VF. Spontaneous 
VF is provoked by a single, long >300 ms coupled PVC. Induced VF can be provoked by 
multiple extrastimuli with shorter coupling interval < 200 ms for VF induced during elec-
trophysiological study [7].
4. Ventricular fibrillation interval (VF interval)
For long time, physicians thought that the amplitude of VF waves (“fine” or “coarse”) is sug-
gestive of defibrillation success, but Murakawa et al. demonstrated on dogs [8] that shorter 
ventricular fibrillation intervals are associated with higher energies for internal defibrillation. 
VF interval is a parameter that can be measured using the ICD electrograms. Kerber et al. [9] 
reported that slower polymorphic VT with cycle length >200 ms needs less energy for defibril-
lation than VF with cycle length of less than 200 ms. Cismaru et al. studied VF cycle length in 
patients with Brugada syndrome, induced VF during electrophysiology study, and showed 
that a longer cycle length that progressively increases is a sign of self‐terminating VF [10] 
(Figures 1 and 2).
Figure 1. Patient with Brugada syndrome and polymorphic VT induction during electrophysiology study. VT stops 
spontaneously without any defibrillation.
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Hiratsuka et al. demonstrated that symptomatic patients with Brugada syndrome have sig-
nificant shorter VF cycle length than asymptomatic patients. The difference is probably given 
by a different electrophysiological substrate between the two groups [11].
5. Unsuccessful internal defibrillation in Brugada syndrome
Patients with Brugada syndrome have higher rates of unsuccessful internal defibrillation after 
the implantation of ICD. The study of Watanabe et al. [12] examined the incidence of VF not 
responding to internal defibrillation and found an incidence of 18%. One explanation could 
be the origin of the electrical abnormality at the level of RVOT [13] with defibrillation shock 
delivered between the right ventricular apex and left subclavicular can. Alternative explana-
tion is the short effective refractory period and short ventricular fibrillation interval (FVI) in 
patients with Brugada syndrome.
6. Intracardiac electrograms (IEGM) compared to morphological 
changes  of an ECG during provocative tests
Probst et al. [14] compared the surface ECG with the intracardiac electrograms (IEGM) from 
internal defibrillator during an ajmaline test in patients with Brugada syndrome. The ECG 
morphology changed after ajmaline injection with ST elevation and negative T‐waves. The 
IEGM showed different morphological changes: ST deviation changes with negative T‐wave 
Figure 2. Patient with Brugada syndrome and ventricular fibrillation induction during electrophysiology study. Please 
note the short VF interval. VF stops after external defibrillation.
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changes. The changes are in contrast with morphological changes from patients without 
Brugada syndrome where IEGM correlates to ST segment deviation on ECG. In countries 
where ajmaline is not available, procainamide can be used for the provocative test.
In the case report of Moore and Kaye, a change of the intracardiac electrogram after an inter-
nal defibrillation was compatible with a type 1 Brugada pattern and disappeared 1 min after 
the electrical shock [15, 16].
7. T‐wave alternans in patients with Brugada syndrome
T‐wave alternans is the ECG manifestation of action potential repolarization alternans. Beat‐to‐
beat alternation of ventricular action potential in both duration and amplitude reflects the risk of 
ventricular tachycardia and ventricular fibrillation [16]. T wave alternance (TWA) from ICD elec-
trograms are concordant with TWA from the surface ECG because they measure the same alter-
nans phenomenon [17] (Figure 3).
Tada et al. described a patient with Brugada syndrome that presented TWA after administra-
tion of a sodium channel blocker (cibenzoline) [18]. Ohkubo et al. also described TWA in a 
patient with Brugada syndrome after class 1 antiarrhythmic drug (pilsicainide). TWA per-
sisted for 15 min and was followed by microvolt TWA [19].
Tada and colleagues [20] investigated the association between ventricular tachycardia 
and fibrillation with TWA induced by intravenous pilsicainide (sodium channel blocker). 
Pilsicainide provoked visible TWA in 17 of 77 Brugada patients. Those with TWA experienced 
a significantly higher incidence of spontaneous VF (52.9 vs. 8.3%) than those without TWA.
Figure 3. Method for determination of TWA: the amplitude for each T‐wave is calculated as the maximum minus the 
minimum value (horizontal red lines). The difference between the amplitude of the first beat and second beat of each pair 
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8. Use of stored ICD electrograms for catheter ablation of ventricular 
fibrillation in Brugada syndrome
Stored electrograms can be used for catheter ablation of ventricular fibrillation. Both far‐field 
EGM and near‐field EGM are used [21]. First, the EGM that initiates ventricular fibrilla-
tion should be captured. This is used as a template for subsequent pacemapping (Figure 4). 
Information regarding the morphology and timing of the EGM are used to search for the best 
correlation during pacemap. Both spontaneous QRS complex morphology and far‐field ICD 
morphology are used for comparison with the paced morphology. Timing between far‐field and 
near‐field ICD electrograms is also used for the template when comparing with the paced beat.
Pacemapping is attempted at the level of RVOT with real‐time recording from the ICD elec-
trogram. Both morphology and timing are used to delineate the zone with the best match and 
that zone will be a target for ablation. The study of Almendral et al. [22] showed spatial reso-
lution of 2 cm2 for best match with electrogram morphology and timing. The same resolution 
was confirmed by Lowery et al. in patients with different types of ventricular fibrillation [21].
Substrate epicardial mapping is initiated in sinus rhythm to identify dense scar <0.5 V and 
border zone between 0.5–1.5 V. Abnormal electrograms consist in low amplitude–wide dura-
tion of >80 ms, with multiple or delayed components outside the end of the surface ECG 
QRS. The same RVOT zone is remapped after IV flecainide to determine increase in abnormal 
electrogram area after infusion. Catheter ablation targets the complete elimination of the sub-
strate inside the low‐voltage areas [23].
Figure 4. Example of pacemapping of a trigger arising from the RVOT in a patient with Brugada syndrome. Panel A 
corresponds to the recorded spontaneous PVC inducing VF (A). Panels B and C show near‐ and far‐field electrograms 
with a bad correlation between the spontaneous RVOT (B) and paced electrogram (C).
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9. Examples of ICD electrograms
We present electrograms from our cardiology department in patients with Brugada syndrome:
• Coupling interval of the PVC initiating ventricular fibrillation (Figures 5 and 6).
• Safe terminating ventricular tachycardia (Figures 7 and 8).
• Ventricular fibrillation terminated by an electrical shock (Figure 9).
Figure 5. The same coupling interval 330 ms and the same PVC morphology at the initiation of nonsustained VT in a 
patient with Brugada syndrome. (A) without PVCs; (B) PVC inducing NSVT; (C) same PVC inducing NSVT; (D) same 
PVC inducing NSVT.
Figure 6. The same coupling interval 322 ms and same morphology at the initiation of nonsustained VT in a patient with 
Brugada syndrome. (A) PVCs with ventricular trigeminism; (B) same PVC inducing NSVT; (C) same PVC inducing (D) 
self‐terminating VF.
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Figure 8. Self‐terminating (or nonsustained) ventricular tachycardia. Please note the long cycle length.
Figure 9. Ventricular fibrillation terminated with an external shock. Please note the short VF interval.
Figure 7. Self‐terminating ventricular tachycardia. Please note the long cycle length. Upper electrogram is the far‐field 
ventricular IEGM; in the middle of the strip atrial IEGM; at bottom near‐field ventricular IEGM.
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10. Conclusion
Analysis of intracardiac electrograms during episodes of ventricular arrhythmias is effective 
for clarifying the mechanism of the episode. Many spontaneous episodes of VF are preceded 
by frequent PVCs. The coupling interval usually is long and reaches the end of the T‐wave. 
Ventricular fibrillation interval is short and may be responsible for failure of internal defibril-
lation. Longer VF interval values predict spontaneous termination of VF. A catheter ablation 
technique was described for catheter ablation of PVCs initiating VF in Brugada syndrome and 
uses the stored IEGMs as template for pacemapping.
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